Navigation Links
Depo Provera Side Effects examined at Congressional Briefing with Rebecca Project for Human Rights, Congressman William Lacy Clay and Other Human Rights Leaders
Date:9/17/2013

WASHINGTON, Sept. 17, 2013 /PRNewswire-USNewswire/ -- U.S. Congressman William Lacy Clay, Jr. (MO), Member of the U.S. Congress and Congressional Black Caucus will hold a Congressional briefing examining Pfizer and health providers targeting women of color to be primary consumers of the carcinogenic contraceptive drug Depo Provera, by concealing of FDA Black Box Warnings and minimizing life-threatening and debilitating side effects. This Depo Provera briefing, in collaboration with the Rebecca Project for Human Rights, is to educate and inform women about lethal side effects of the Depo Provera shot. It will be held at the US Capitol Hill Campus on September 20, 2013 at 3:30PM during the CBC conference week at the Capitol Visitors Center Auditorium. 

Imani Walker, Executive Director of the Rebecca Project stated, "our nonpartisan anti-Depo Provera advocacy is about protecting Black women's reproductive health and protecting low-income communities, because Black women experience significant health disparities."  According to the Centers for Disease Control (CDC), the leading causes of death for Black women are: heart disease, cancer, HIV/AIDS stroke, and diabetes. Furthermore, medical research indicates the use of Depo Provera can cause or exacerbate all those diseases. Therefore, it is imperative that women are counseled and provided informed consent about harm. 

In June 2013, Rebecca Project for Human Rights published a policy report: Depo-Provera: Deadly Reproductive Violence. Kwame Fosu, Policy Director for the Rebecca Project for Human Rights explains, "this is a definitive report that details incidents of misconduct by Pfizer major health providers." In addition, the Rebecca Project analysis also examines reported concerns of Depo Provera research in Ghana.

Pastor Lennox Abrigo, who is President, National Action Network DC Chapter, and President of the Civil & Human Rights Depo Provera Coalition said, "this Depo Provera briefing is going to be a respectful, thoughtful discussion about the dignity and health of Black women, and women of color, in the United States and globally. Our community's harm and voices have to be heard by our elected leaders, Pfizer, Planned Parenthood and all Public Health institutions that continue to promote this dangerous drug without Black Box warnings."

Other health and women's rights leaders participating at the Congressional briefing are: Dr. Charlotte Charity Abaka, former Chairperson of Committee on the Elimination of Discrimination Against Women (CEDAW); Grace Akallo, Executive Director, United Africans for Women and Children Rights; Rev. Brook Parker Bello, Executive Director, Above the Noise; Dr. Joel Brind, Professor of Biology and Endocrinology, CUNY; Ms. Lisa Davis, Chairperson of Black is Back Coalition Healthcare Working Group; Reverend Marcia Dyson, The Dyson Report; Kwame Fosu, Policy Director, Rebecca Project for Human Rights; Dr. Steve Minkin, Public Health HIV AIDS Expert; Elize Lotter, a South Africa Human Rights Advocate permanently harmed by Depo Provera; Jesse Morrow, Social Reform Director, Church of Scientology, National Affairs Office; Professor Charles Ogletree, Harvard Law Professor; Reverend Marvin Owens, Jr., Senior Pastor of Michigan Park; Elaine Riddick, Women's Rights Activist, forcibly sterilized in 1968 at age 13 and fought back to help secure a $10 million settlement for victims; Minister Dr. Randy Short, Social Justice Minister and National Spokesperson and President of the Clergy Coalition; and Imani Walker, Executive Director, Rebecca Project for Human Rights.

For more information about Depo Provera, please contact Kwame Fosu or Imani Walker at 202-406-0911 or 202-265-3906, or go to the Rebecca Project website at http://www.rebeccaproject.org/.


'/>"/>
SOURCE Rebecca Project for Human Rights
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
2. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
3. Side Effects Limit Prescription Drug Compliance
4. Garcinia Cambogia Extract Truth Exposed: Reviews, Side Effects & Where To Buy
5. Life After Failing TVM Treatments is a Rollercoaster of Side Effects for Women
6. Adverse Effects in AIM-HIGH trial of Niaspan are Consistent With the Results Reported From HPS2-THRIVE Trial of ER Niacin Plus Laropiprant
7. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
8. Niacin Causes Serious Unexpected Side-effects, but no Worthwhile Benefits, for Patients who are at Increased Risk of Heart Attacks and Strokes
9. New Study Shows Cannabis Effects on Driving Skills
10. Fox News Medical Contributor Explains Study of Side Effects from Prostate-Cancer Treatments
11. Star Scientific Reports Publication of First Peer-Reviewed Article on the Effects of Anatabine in an Animal Model of Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... ... ... The American Board of Family Medicine's (ABFM) Board of Directors has selected Warren ... James C. Puffer upon his retirement. Dr. Newton will serve in the position of ... end of 2018. Upon assuming the role of President and CEO on January 1, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of ... ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership in ... It also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
Breaking Medicine News(10 mins):